secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001171843-25-006317
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical reports preliminary Q3 revenue $5.2-5.3M, up 84-87% YoY
------------------------------------------------------------------------

- Preliminary unaudited Q3 2025 revenue of $5.2-5.3M vs $2.8M in Q3 2024, growth 84-87%.
- Gross margin expected ~72% compared to 64% in prior-year period.
- TULSA-PRO installed base grew to 67 from 60; full-year target of at least 75 systems.
- Full Q3 2025 results and conference call scheduled for November 13, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184325006317/0001171843-25-006317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184325006317/f8k_100725.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-006317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer